Defunct Company
Total Trials
26
As Lead Sponsor
23
As Collaborator
3
Total Enrollment
2,286
NCT00105495
Efficacy Study in Removing Excess Iron From the Heart
Phase: Phase 4
Role: Lead Sponsor
Start: Dec 31, 2002
Completion: Oct 31, 2004
NCT00387101
Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
Phase: Phase 3
Start: Feb 28, 2006
Completion: Apr 30, 2008
NCT00293098
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Phase: N/A
Role: Collaborator
Start: Mar 31, 2006
Completion: Not specified
NCT02191657
Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects
Phase: Phase 1
Start: Nov 30, 2006
Completion: Apr 30, 2010
NCT00529152
Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
Start: Aug 31, 2007
Completion: Jul 31, 2008
NCT00530127
A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Phase: Phase 1/2
Start: Apr 30, 2008
Completion: Jul 31, 2009
NCT00897221
A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Phase: Phase 2
Start: Jun 30, 2009
Completion: Mar 31, 2011
NCT01838291
Active Drug Surveillance Program of Ferriprox Use
Start: Jun 30, 2010
Completion: Apr 30, 2013
NCT01483924
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Start: Nov 30, 2011
Completion: Oct 31, 2013
NCT01860703
Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
Start: Nov 30, 2012
Completion: Jul 31, 2013
NCT01741532
Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Start: Dec 13, 2012
Completion: Jan 11, 2017
NCT01767103
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
Start: Jan 31, 2013
Completion: Apr 30, 2014
NCT01770652
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment
Completion: Aug 31, 2013
NCT01835496
Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease
Start: May 31, 2013
NCT02164253
Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients
Start: Sep 30, 2013
Completion: Dec 31, 2016
NCT01989455
A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers
Start: Nov 30, 2013
Completion: Mar 31, 2014
NCT02041299
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Start: Apr 17, 2014
Completion: Jun 18, 2019
NCT02189941
Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers
Start: May 31, 2014
Completion: Jun 30, 2014
NCT02174848
Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Start: Jun 30, 2014
Completion: Mar 16, 2018
NCT02443545
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
Start: May 21, 2015
Completion: Aug 21, 2019
NCT02442310
Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers
Start: May 31, 2015
Completion: Jul 31, 2015
NCT02456558
Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects
Start: Jun 30, 2015
Completion: May 31, 2016
NCT02465489
Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers
Completion: Aug 31, 2015
NCT02655315
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease
Start: Feb 9, 2016
Completion: Sep 22, 2020
NCT02728843
Study of Parkinson's Early Stage With Deferiprone
Start: Oct 12, 2016
Completion: Sep 4, 2019
NCT03802916
Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload
Start: Mar 6, 2019
Completion: Dec 19, 2019